July 29, 2016
BIOPHYTIS receives approval of bpifrance for an innovation loan of €1.1M to finance the SARA-PK trial. Read the press release
BIOPHYTIS receives approval of bpifrance for an innovation loan of €1.1M to finance the SARA-PK trial. Read the press release
BIOPHYTIS receives Belgian regulatory authorization to start Sarconeos pharmacokinetics study in elderly healthy volunteers (SARA-PK). Read the Press Release
Results of the Combined General Shareholders’ Meeting held on June 10, 2016. Read the Press Release
BIOPHYTIS to attend BIO International Convention in San Francisco, June 6th to 9th 2016. Read the Press Release and watch the video of Stanislas Veillet
In french: Assemblée Générale convoquée le 10 juin 2016. Téléchargez le communiqué de presse
BIOPHYTIS unveils its clinical development strategy in the United States, as it communicates its 2015 Document de Référence. Download the Press Release
BIOPHYTIS to Present Key Research Findings on Company’s Two Lead Compounds at Upcoming Scientific Conferences. Read the Press Release
BIOPHYTIS receives positive scientific advice on SARCOB BIO101 clinical development plan from Belgian regulatory authority. Download the Press Release
American LifeSci Capital initiates coverage of Biophytis stock. Téléchargez le communiqué de presse. Téléchargez le communiqué de presse